Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Olson

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Case Reports in Cardiology|May 15, 2014
Cardiac sarcoidosis or giant cell myocarditis? On treatment improvement of fulminant myocarditis as demonstrated by cardiovascular magnetic resonance imagingHari Bogabathina, Peter Olson, Vikas K Rathi, et al.
Cancer Cell|February 9, 2010
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent MannerNeta Erez, Morgan Truitt, Peter Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinomaPeter Olson, Gerald C Chu, Samuel R Perry, et al.
Anesthesiology|May 1, 2002
Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding studyJerrold H Levy, George J Despotis, Fania Szlam, et al.
The Pharmacogenomics Journal|March 5, 2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient populationAdith S Arun, David Liarakos, Gaurav Mendiratta, et al.
Oncotarget|November 9, 2018
Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinomaXuran Yang, Wei Xia, Lin Chen, et al.
Genes & Cancer|October 27, 2010
Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytesOlivier Nolan-Stevaux, Morgan C Truitt, Jessica C Pahler, et al.
Plos One|November 12, 2015
Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor ProgressionTao Xie, Monica Musteanu, Pedro P Lopez-Casas, et al.
Cureus|July 11, 2022
Repeat Revascularization Post Coronary Artery Bypass Grafting: Comparing Minimally Invasive and Traditional Sternotomy Techniques in 1468 CasesPeter Olson, Michael Cinelli, Hamfreth S Rahming, et al.
Nature Medicine|November 20, 2003
Muscle-specific Pparg deletion causes insulin resistanceAndrea L Hevener, Weimin He, Yaacov Barak, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Case Reports in Cardiology|May 15, 2014
Cardiac sarcoidosis or giant cell myocarditis? On treatment improvement of fulminant myocarditis as demonstrated by cardiovascular magnetic resonance imagingHari Bogabathina, Peter Olson, Vikas K Rathi, et al.
Cancer Cell|February 9, 2010
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent MannerNeta Erez, Morgan Truitt, Peter Olson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinomaPeter Olson, Gerald C Chu, Samuel R Perry, et al.
Anesthesiology|May 1, 2002
Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding studyJerrold H Levy, George J Despotis, Fania Szlam, et al.
The Pharmacogenomics Journal|March 5, 2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient populationAdith S Arun, David Liarakos, Gaurav Mendiratta, et al.
Oncotarget|November 9, 2018
Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinomaXuran Yang, Wei Xia, Lin Chen, et al.
Genes & Cancer|October 27, 2010
Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytesOlivier Nolan-Stevaux, Morgan C Truitt, Jessica C Pahler, et al.
Plos One|November 12, 2015
Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor ProgressionTao Xie, Monica Musteanu, Pedro P Lopez-Casas, et al.
Cureus|July 11, 2022
Repeat Revascularization Post Coronary Artery Bypass Grafting: Comparing Minimally Invasive and Traditional Sternotomy Techniques in 1468 CasesPeter Olson, Michael Cinelli, Hamfreth S Rahming, et al.
Nature Medicine|November 20, 2003
Muscle-specific Pparg deletion causes insulin resistanceAndrea L Hevener, Weimin He, Yaacov Barak, et al.
Pageof 7